Therapist Fidelity With an Exposure-Based Treatment of PTSD in Adults With Schizophrenia or Schizoaffective Disorder

被引:9
|
作者
Long, Mary E. [1 ,2 ]
Grubaugh, Anouk L. [2 ,3 ]
Elhai, Jon D. [4 ]
Cusack, Karen J. [5 ]
Knapp, Rebecca [3 ]
Frueh, B. Christopher [6 ]
机构
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Vet Affairs Med Ctr, Minneapolis, MN USA
[3] Med Univ S Carolina, Charleston, SC USA
[4] Univ Toledo, Toledo, OH USA
[5] Univ N Carolina, Chapel Hill, NC 27515 USA
[6] Univ Hawaii, Honolulu, HI 96822 USA
关键词
PTSD; cognitive-behavioral therapy; therapist fidelity; severe mental illness; MULTICOMPONENT BEHAVIORAL TREATMENT; POSTTRAUMATIC-STRESS-DISORDER; TREATMENT INTEGRITY; TRAUMA; INTERVENTION; COMPETENCE;
D O I
10.1002/jclp.20657
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
This study examined therapists' fidelity to a manualized, multi-component cognitive-behavioral intervention for posttraumatic stress disorder (PTSD), including exposure therapy, among public sector patients with a psychotic disorder. Independent raters assessed therapists' competence and adherence, rating 20% of randomly selected audio taped sessions (n = 57 sessions, coded by two raters, with strong interrater agreement). Adherence ratings indicated that therapists complied well with the protocol, and competency ratings typically averaged "very good" or higher (6 on 7-point Likert scale). Findings suggest that therapists can effectively deliver a manualized cognitive-behavioral intervention for PTSD, with exposure therapy, to patients with severe mental illness without compromise to the structure of sessions and/or the therapeutic relationship. (C) 2010 Wiley Periodicals, Inc. J Clin Psychol 66:383-393, 2010.
引用
收藏
页码:383 / 393
页数:11
相关论文
共 50 条
  • [21] Exposure and non-fear emotions: A randomized controlled study of exposure-based and rescripting-based imagery in PTSD treatment
    Langkaas, Tomas Formo
    Hoffart, Asle
    Oktedalen, Tuva
    Ulvenes, Pal G.
    Hembree, Elizabeth A.
    Smucker, Mervin
    BEHAVIOUR RESEARCH AND THERAPY, 2017, 97 : 33 - 42
  • [22] Moving forward in treatment of posttraumatic stress disorder: innovations to exposure-based therapy
    Nijdam, Mirjam J.
    Vermetten, Eric
    EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY, 2018, 9 (01):
  • [23] Light exposure and quality of life in older schizophrenia and schizoaffective disorder patients
    Martin, J
    Jeste, DV
    Patterson, T
    Ancoli-Israel, S
    BIOLOGIC EFFECTS OF LIGHT 1998, 1999, : 471 - 473
  • [24] Approaches to common obstacles in the exposure-based treatment of obsessive-compulsive disorder
    Abramowitz, JS
    Franklin, ME
    Cahill, SR
    COGNITIVE AND BEHAVIORAL PRACTICE, 2003, 10 (01) : 14 - 22
  • [25] Characteristics and Service Use of Older Adults with Schizoaffective Disorder Versus Older Adults with Schizophrenia and Bipolar Disorder
    Rolin, Stephanie A.
    Aschbrenner, Kelly A.
    Whiteman, Karen L.
    Scherer, Emily
    Bartels, Stephen J.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2017, 25 (09): : 941 - 950
  • [26] Long-acting risperidone in young adults with schizophrenia and schizoaffective disorder
    Lasser, R
    Bossier, C
    Zhu, Y
    Ciliberto, N
    Trinh, B
    Kane, J
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S236 - S236
  • [27] Does cumulative exposure to traumatic stressors predict treatment outcome of community-implemented exposure-based therapy for PTSD?
    Schneider, Anna
    Pfeiffer, Anett
    Conrad, Daniela
    Elbert, Thomas
    Kolassa, Iris-Tatjana
    Wilker, Sarah
    EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY, 2020, 11 (01)
  • [28] Treatment with rosuvastatin for severe dyslipidaemia in patients with schizophrenia and Schizoaffective disorder
    De Hert, M.
    Kalnicka, D.
    van Winkel, R.
    Wampers, M.
    Hanssens, L.
    Van Eyck, D.
    Scheen, A.
    Peuskens, J.
    DRUG SAFETY, 2006, 29 (10) : 1002 - 1002
  • [29] Combined clozapine-lithium treatment in schizophrenia and schizoaffective disorder
    Moldavsky, M
    Stein, D
    Benatove, R
    Sirota, P
    Weizman, A
    Elizur, A
    SCHIZOPHRENIA RESEARCH, 1996, 18 (2-3) : VA10 - VA10
  • [30] Risperidone versus olanzapine in the treatment of patients with schizophrenia or schizoaffective disorder
    Brecher, M
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 271 - 271